Shelter Growth Capital Partners is focuses on sourcing and creating investments
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
A fast-growing integrated investment and mortgage acquisition platform focused throughout the country, SG Capital Partners concentrates on directing private capital to the U.S. housing market. The firm employs an investment approach that is based on identifying the best risk-adjusted opportunities and helping clients to invest in a diverse array of assets and investment vehicles. SG Capital Partners has focused its investment activity primarily on structured fixed income markets and mortgage-related assets such as mortgage servicing rights, agency mortgage-backed securities, structured fixed-income instruments, and more. SG Capital Partners dedicates substantial effort and resource toward effective risk management. Through its experienced management team and a strong foundation of corporate governance, the firm has experience managing large investment portfolios in a variety of market conditions. In addition, the firm uses proprietary technology and industry-leading analysis tools to monitor markets and assess portfolio risk. In particular, the firm adheres to its risk management core components of fundamental market and sector assessments, prudent balance sheet management, controlled risk exposure, and disciplined asset selection. Aside from its work in investment management, SG Capital provides the capital necessary to acquire residential mortgage loans through its conduit correspondent network. The firm has experienced partners nationwide who originate loans for SG Capital’s credit programs. As a result of its efficient loan acquisition system, large suite of loan products, and a dedicated team of support specialists, SG Capital is able to address its originating clients’ challenges and production goals.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2001 | Signature BioScience | Series D | 0 |
5/2000 | Princeton Review | Venture Round | 0 |
5/2000 | National Technological University | Series B | 0 |
3/2002 | Signature BioScience | Series E | 0 |
9/2000 | Exario Networks | Series A | 0 |
2/2000 | MarketSwitch | Series B | 0 |
8/2000 | Princeton eCom | Venture Round | 0 |
3/2002 | Signature BioScience | Series E | 0 |
7/2001 | Signature BioScience | Series D | 0 |
9/2000 | Exario Networks | Series A | 0 |
8/2000 | Princeton eCom | Venture Round | 0 |
5/2000 | National Technological University | Series B | 0 |
5/2000 | Princeton Review | Venture Round | 0 |
2/2000 | MarketSwitch | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|